Anika Therapeutics ANIK
NASDAQ ANIK
$20.88 -0.16 (-0.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Anika Therapeutics (ANIK) Divestments (2025)

Anika Therapeutics' (ANIK) quarterly Divestments came in at $4.5 million in Q1 2025.

Analysis

Anika Therapeutics (ANIK) Divestments (2025) Analysis & Trends

Anika Therapeutics (ANIK) has reported Divestments for 1 consecutive years, with $4.5 million the latest figure, recorded in Q1 2025.

  • On a quarterly basis, Divestments changed N/A year-over-year to $4.5 million in Q1 2025; TTM through Dec 2025 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.5 million, changed N/A from the prior year.
  • Divestments was $4.5 million for Q1 2025 at Anika Therapeutics.
  • Over five years, Divestments peaked at $4.5 million in Q1 2025 and troughed at $4.5 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -
10 Anika Therapeutics 277.93 Mn 239.52 Mn 21.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4.50 Mn